Jun 10, 2020 / 07:50PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Good afternoon, everyone. My name is Graig Suvannavejh. I cover European and U.S. biopharma for the firm. Let me welcome you to the 3:50 p.m. session of day 2 of the Goldman Sachs Global Healthcare Conference. I've got the pleasure of introducing Alector to you all today. And joining us from the company, we've got 3 members of the leadership team. Shehnaaz Suliman, who's the President, and Chief Operating Officer of the company; Robert Paul, who's the Chief Medical Officer; and Sabah Oney, who is the Chief Business Officer.
So let me welcome the 3 of you to your first Goldman Sachs Healthcare Conference. In normal times, we'll be doing this South of Southern California, a much better venue.
Hopefully, we can get back to a time where we can do this in person. But thank you for joining us.
Maybe just to start off, as Alector is a relatively new company, maybe I'll turn it to you Shehnaaz just to give us kind of a high-level introduction as to who Alector is,
Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
